The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
The crystal structure of dipeptidyl peptidase IV (CD26) reveals its functional regulation and enzymatic mechanism
Open accessAbstract
The membrane-bound glycoprotein dipeptidyl peptidase IV (DP IV, CD26) is a unique multifunctional protein, acting as receptor, binding and proteolytic molecule. We have determined the sequence and 1.8 Å crystal structure of native DP IV prepared from porcine kidney. The crystal structure reveals a 2-2-2 symmetric tetrameric assembly which depends on the natively glycosylated β-propeller blade IV. The crystal structure indicates that tetramerization of DP IV is a key mechanism to regulate its interaction with other components. Each subunit comprises two structural domains, the N-terminal eight-bladed β-propeller with open Velcro topology and the C-terminal α/β-hydrolase domain. Analogy with the structurally related POP and tricorn protease suggests that substrates access the buried active site through the β-propeller tunnel while products leave the active site through a separate side exit. A dipeptide mimicking inhibitor complexed to the active site discloses key determinants for substrate recognition, including a Glu–Glu motif that distinguishes DP IV as an aminopeptidase and an oxyanion trap that binds and activates the P 2-carbonyl oxygen necessary for efficient postproline cleavage. We discuss active and nonactive site-directed inhibition strategies of this pharmaceutical target protein.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
[20] Processing of X-ray diffraction data collected in oscillation mode
Otwinowski, Z., & Minor, W. (1997) · Methods in Enzymology · doi:10.1016/s0076-6879(97)76066-x · Cited by 33,475
The CCP4 suite: programs for protein crystallography
Collaborative Computational Project, N. 4. (1994) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444994003112 · Cited by 17,270
Crystallography & NMR System: A New Software Suite for Macromolecular Structure Determination
Brünger, A. T., Adams, P. D., Clore, G. M., DeLano, W. L., Gros, P., Grosse-Kunstleve, R. W., Jiang, J. S., Kuszewski, J., Nilges, M., Pannu, N. S., et al. (1998) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444998003254 · Cited by 15,715
MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures
Kraulis, P. J. (1991) · Journal of Applied Crystallography · doi:10.1107/s0021889891004399 · Cited by 14,085
Nicholls, A., Sharp, K. A., & Honig, B. (1991) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.340110407 · Cited by 5,240
[26] Raster3D: Photorealistic molecular graphics
Merritt, E. A., & Bacon, D. J. (1997) · Methods in Enzymology · doi:10.1016/s0076-6879(97)77028-9 · Cited by 3,739
Dipeptidyl-peptidase IV (CD26)-role in the inactivation of regulatory peptides
Mentlein, R. (1999) · Regulatory Peptides · doi:10.1016/s0167-0115(99)00089-0 · Cited by 1,272
Methods used in the structure determination of bovine mitochondrial F1 ATPase
Abrahams, J. P., & Leslie, A. G. W. (1996) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444995008754 · Cited by 1,089
Esnouf, R. M. (1999) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444998017363 · Cited by 753
Scanlan, M. J., Raj, B. K., Calvo, B., Garin-Chesa, P., Sanz-Moncasi, M. P., Healey, J. H., Old, L. J., & Rettig, W. J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.12.5657 · Cited by 574
Proline-Dependent Structural and Biological Properties of Peptides and Proteins
Yaron, A., Naider, F., & Scharpe, S. (1993) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409239309082572 · Cited by 551
Direct Association of Adenosine Deaminase with a T Cell Activation Antigen, CD26
Kameoka, J., Tanaka, T., Nojima, Y., Schlossman, S. F., & Morimoto, C. (1993) · Science · doi:10.1126/science.8101391 · Cited by 507
Fülöp, V., Böcskei, Z., & Polgár, L. (1998) · Cell · doi:10.1016/s0092-8674(00)81416-6 · Cited by 496
Crystal structure of human dipeptidyl peptidase IV/CD26 in complex with a substrate analog
Rasmussen, H. B., Branner, S., Wiberg, F. C., & Wagtmann, N. (2003) · Nature Structural Biology · doi:10.1038/nsb882 · Cited by 424
CD26: a surface protease involved in T-cell activation
Fleischer, B. (1994) · Immunology Today · doi:10.1016/0167-5699(94)90316-6 · Cited by 325
Pederson, R. A., White, H. A., Schlenzig, D., Pauly, R. P., McIntosh, C. H. S., & Demuth, H.-U. (1998) · Diabetes · doi:10.2337/diab.47.8.1253 · Cited by 267
Self-citationTong, L., & Rossmann, M. G. (1990) · Acta Crystallographica Section A Foundations of Crystallography · doi:10.1107/s0108767390005530 · Cited by 257
Therapeutic potential of dipeptidyl peptidase IV inhibitors for the treatment of type 2 diabetes
Drucker, D. (2003) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.12.1.87 · Cited by 237
β Propellers: structural rigidity and functional diversity
Fülöp, V., & Jones, D. T. (1999) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(99)00035-4 · Cited by 231
Cheng, J. D., Dunbrack, R. L., Valianou, M., Rogatko, A., Alpaugh, R. K., & Weiner, L. M. (2002) · PubMed · Cited by 217
Cheng, H.-C., Abdel-Ghany, M., Elble, R. C., & Pauli, B. U. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.37.24207 · Cited by 168
Pospisilik, J. A., Stafford, S. G., Demuth, H., McIntosh, C. H. S., & Pederson, R. A. (2002) · Diabetes · doi:10.2337/diabetes.51.9.2677 · Cited by 146
Self-citationIsolation and Characterization of Dipeptidyl Peptidase IV from Human Placenta
PÜSCHEL, G., Mentlein, R., & Heymann, E. (1982) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1982.tb06788.x · Cited by 143
Abbott, C. A., McCaughan, G. W., & Gorrell, M. D. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)01166-7 · Cited by 120
Kiefersauer, R. A., Than, M. E., Dobbek, H., Gremer, L., Melero, M., Strobl, S., Dias, J. M. L., Soulimane, T., & Huber, R. (2000) · Journal of Applied Crystallography · doi:10.1107/s0021889800008049 · Cited by 116
Self-citationKajiyama, H., Kikkawa, F., Suzuki, T., Shibata, K., Ino, K., & Mizutani, S. (2002) · PubMed · Cited by 115
Crystal structure of the tricorn protease reveals a protein disassembly line
Brandstetter, H., Kim, J., Groll, M., et al. (2001) · Nature · doi:10.1038/35106609 · Cited by 99
Self-citationFischer, G. S., Heins, J., & Barth, A. (1983) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/0167-4838(83)90261-3 · Cited by 90
Duke‐Cohan, J. S., Morimoto, C., Rocker, J. A., & Schlossman, S. F. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.5.1714 · Cited by 87
Abbott, C. A., McCaughan, G. W., Levy, M. T., Church, W. B., & Gorrell, M. D. (1999) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1999.00902.x · Cited by 87
2-cyanopyrrolidides as potent, stable inhibitors of dipeptidyl peptidase IV
Ashworth, D. M., Atrash, B., Baker, G. R., Baxter, A., Jenkins, P. D., Jones, D. M., & Szelke, M. (1996) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/0960-894x(96)00190-4 · Cited by 85
Medrano, F. J., Alonso, J., García, J. L., Romero, A., Bode, W., & Gomis‐Rüth, F. X. (1998) · The EMBO Journal · doi:10.1093/emboj/17.1.1 · Cited by 82
Self-citationLin, J., Toscano, P. J., & Welch, J. T. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.24.14020 · Cited by 79
CD26-processed RANTES(3–68), but not intact RANTES, has potent anti-HIV-1 activity
Schols, D., Proost, P., Struyf, S., Wuyts, A., Meester, I. D., Scharpé, S., Damme, J. V., & Clercq, E. D. (1998) · Antiviral Research · doi:10.1016/s0166-3542(98)00039-4 · Cited by 77
Metabolism of glucagon by dipeptidyl peptidase IV (CD26)
Pospisilik, J. A., Hinke, S. A., Pederson, R. A., Hoffmann, T., Rosche, F., Schlenzig, D., Glund, K., Heiser, U. F., McIntosh, C. H. S., & Demuth, H. (2001) · Regulatory Peptides · doi:10.1016/s0167-0115(00)00170-1 · Cited by 70
Self-citationHo, L., Aytac, U., Stephens, L. C., Ohnuma, K., Mills, G. B., McKee, K. S., Neumann, C., LaPushin, R., Cabanillas, F., Abbruzzese, J. L., et al. (2001) · PubMed · Cited by 68
Metabolism and functions of neuropeptide Y
Medeiros, M. D. S., & Turner, A. J. (1996) · Neurochemical Research · doi:10.1007/bf02532423 · Cited by 58
Dipeptidylpeptidase Iv - Inactivation with N-Peptidyl-O-Aroyl Hydroxylamines
Demuth, H., Baumgrass, R., Schaper, C., Fischer, G. S., & Barth, A. (1988) · Journal of enzyme inhibition · doi:10.3109/14756368809040718 · Cited by 53
Self-citationGoettig, P., Groll, M., Kim, J., Huber, R., & Brandstetter, H. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf552 · Cited by 51
Self-citationLambeir, A., Pereira, J. F. D., Chacón, P., Vermeulen, G., Heremans, K., Devreese, B. V., BEEUMEN, J. V., Meester, I. D., & Scharpé, S. (1997) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/s0167-4838(97)00045-9 · Cited by 50
Distribution of adenosine deaminase-complexing protein in murine tissues
Dinjens, W. N. M., ten Kate, J., Wijnen, J., van der Linden, E. P. M., Beek, C. J., Lenders, M. ‐., Khan, P. M., & Bosman, F. T. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)47289-x · Cited by 46
Reactions Between Dipeptidyl Peptidase Iv and Diacyl Hydroxylamines: Mechanistic Investigations
Demuth, H., Neumann, U., & Barth, A. (1989) · Journal of enzyme inhibition · doi:10.3109/14756368909088477 · Cited by 37
Self-citationKASPARI, A., Diefenthal, T., Grosche, G., Schierhorn, A., & Demuth, H. U. (1996) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/0167-4838(95)00238-3 · Cited by 34
Self-citationCD26/Dipeptidyl Peptidase IV Does Not Work as an Adenosine Deaminase-Binding Protein in Rat Cells
Iwaki-Egawa, S., Watanabe, Y., & Fujimoto, Y. (1997) · Cellular Immunology · doi:10.1006/cimm.1997.1123 · Cited by 23
[48] N,O-Diacyl hydroxamates as selective and irreversible inhibitors of cysteine proteinases
Brömme, D., & Demuth, H. (1994) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(94)44050-6 · Cited by 22
Self-citationPeptidyl Ammonium Methyl Ketones as Substrate Analog Inhibitors of Proline-Specific Peptidases
Steinmetzer, T., Silberring, J., Mrestani‐Klaus, C., FITTKAU, S., Barth, A., & Demuth, H. (1993) · Journal of enzyme inhibition · doi:10.3109/14756369309040750 · Cited by 18
Self-citationTherapeutic Strategies Exploiting DP IV Inhibition: Target disease: Type 2 Diabetes
Hoffmann, T., & Demuth, H. (2002) · Springer eBooks · doi:10.1007/978-1-4615-0619-5_10 · Cited by 9
Self-citation
Cited by
Kim, D., Wang, L., Beconi, M., Eiermann, G. J., Fisher, M. H., He, H., Hickey, G. J., Kowalchick, J. E., Leiting, B., Lyons, K., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm0493156 · Cited by 822
Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26
Lu, G., Hu, Y., Wang, Q., Qi, J., Gao, F., Li, Y., Zhang, Y., Zhang, W., Yuan, Y., Bao, J., et al. (2013) · Nature · doi:10.1038/nature12328 · Cited by 739
Augeri, D. J., Robl, J. A., Betebenner, D. A., Magnin, D. R., Khanna, A., Robertson, J. G., Wang, A., Simpkins, L. M., Taunk, P., Huang, Q., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050261p · Cited by 624
Pharmacology, Physiology, and Mechanisms of Action of Dipeptidyl Peptidase-4 Inhibitors
Mulvihill, E. E., & Drucker, D. J. (2014) · Endocrine Reviews · doi:10.1210/er.2014-1035 · Cited by 609
Bat-to-human: spike features determining ‘host jump’ of coronaviruses SARS-CoV, MERS-CoV, and beyond
Lu, G., Wang, Q., & Gao, G. F. (2015) · Trends in Microbiology · doi:10.1016/j.tim.2015.06.003 · Cited by 607
Metadata
- Authors
- Engel, M., Hoffmann, T., Wagner, L., Wermann, M., Heiser, U., Kiefersauer, R., Huber, R., Bode, W., Demuth, H.-U., & Brandstetter, H.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2003-04-10
- Volume
- 100
- Issue
- 9
- Pages
- 5063-5068
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2155060077
- Cited by
- 305
- References
- 47
- FWCI
- 10.10
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.